Drug recall · February 12, 2014
Glucotrol XL recall
Why: Failed Dissolution Specification; 8 hr stability timepoint
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Glucotrol XL (glipizide) extended release tablets, 5 mg, 100 count bottles, Rx only, Distributed by Roerig, Division of Pfizer Inc, NY, NY --- NDC 0049-1550-66
- Lots / codes
Lot V120131
- Quantity
- 14,357 bottles
- Company
- Pfizer Inc., New York, NY
- Distribution
- US nationwide (including PR)
- Initiated
- November 4, 2013 · Voluntary: Firm initiated
- Classified
- February 3, 2014
- Reported
- February 12, 2014
- Ended
- June 24, 2015
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Glipizide
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.